IMR Press / EJGO / Volume 40 / Issue 4 / DOI: 10.12892/ejgo4484.2019
Open Access Original Research
The role of vitamin D up-regulated protein 1 in epithelial ovarian cancer
Show Less
1 Department of Obstetrics and Gynecology, Green OBGY Clinic, Incheon, Republic of Korea
2 Department of Obstetrics and Gynecology, Soonchunhyang University College of Medicine, Cheonan, Republic of Korea
3 Department of Obstetrics and Gynecology, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea
4 Department of Interdisciplinary Program in Biomedical Science, Soonchunhyang University, Asan, Republic of Korea

Contributed equally.

Eur. J. Gynaecol. Oncol. 2019, 40(4), 585–592;
Revised: 8 November 2017 | Published: 10 August 2019

Purpose: The objective of this study was to verify the relationship between the expression of VDP1 and Jun activation domain-binding protein 1 (Jab1) and cyclin-dependent kinase inhibitor 1B (CDKN1B: p27kip1) in ovarian cancer cell strains. Materials and Methods: The ovarian cancer cell lines SK-OV-3, OVCAR-3 were plated and cultivated for 24 hours in a 37°C carbon dioxide incubator. Thereafter, vitamin D was added at various concentrations, and the cells were cultivated for an additional 24 hours. Using the 3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide (MTT) assay, cell growth was checked, and changes in the protein level were observed using Western blotting, immunofluorescence and immunocytochemistry. Results: The authors found that the viability of the ovarian cancer cells was decreased by vitamin D, dose dependently. The results of Western blotting, immunofluorescence, and immunocytochemistry revealed that p27kip1 and VDUP1 increased, while Jab1 decreased, dose dependently. Conclusion: These findings show the relationship between p27kip1, Jab1 and VDUP1 following vitamin D treatment in ovarian cancer, indicating a correlation with cancer cell proliferation.

Epithelial ovarian neoplasms
VDUP1 protein
Vitamin D
Figure 1.
Back to top